THOUSAND OAKS PATHOLOGY ASSOCIATES INC NPI 1912930900

NPI Details

THOUSAND OAKS PATHOLOGY ASSOCIATES INC is a clinical medical laboratory in Thousand Oaks, CA. The provider is (1) A clinical laboratory is a facility for the biological, microbiological, serological, chemical, immunohematological, hematological, biophysical, cytological, pathological, or other examination of materials derived from the human body for the purpose of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, human beings. These examinations also include procedures to determine, measure, or otherwise describe the presence or absence of various substances or organisms in the body. Facilities only collecting or preparing specimens (or both) or only serving as a mailing service and not performing testing are not considered clinical laboratories. (2) Any facility that examines materials from the human body for purposes of providing information for the diagnosis, prevention, or treatment of any disease or impairment of, or the assessment of, the health of human beings. Typical divisions of a clinical laboratory include hematology, cytology, bacteriology, histology, biochemistry, medical toxicology, and serology. THOUSAND OAKS PATHOLOGY ASSOCIATES INC NPI is 1912930900. The provider is registered as an organization entity type.

The provider's business location address is:

351 ROLLING OAKS DR
SUITE 100
THOUSAND OAKS, CA
ZIP 91361-275
Phone: (805) 373-8582
Fax: (805) 373-0023

The provider's authorized official is Wayne Merritt Schultheis .
The authorized official title is Pathologist/managing Partner and has the following contact phone number (805) 373-8582.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Pathology examination of tissue using a microscope, intermediate complexity (HCPCS:88305)
• Special stained specimen slides to identify organisms including interpretation and report (HCPCS:88312)
• Special stained specimen slides to examine tissue, each additional procedure (HCPCS:88341)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r (HCPCS:U0003)
• Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within (HCPCS:U0005)
• Microscopic genetic analysis of tumor, manual (HCPCS:88360)
• Special stained specimen slides to examine tissue, initial procedure (HCPCS:88342)
• Pathology examination of tissue using a microscope, moderately low complexity (HCPCS:88304)
• Pap test, automated thin layer preparation; automated system and manual rescreening (HCPCS:88175)
• Special stained specimen slides to examine tissue including interpretation and report (HCPCS:88313)
• Detection test by nucleic acid for multiple types of respiratory virus, multiple types or subtypes, 3-5 targets (HCPCS:87631)
• Preparation of tissue for examination by removing any calcium present (HCPCS:88311)
• Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision (HCPCS:G0145)
• Detection test by nucleic acid for organism, amplified probe technique (HCPCS:87798)
• Pathology examination of tissue using a microscope, moderately high complexity (HCPCS:88307)
• Evaluation of fine needle aspirate with interpretation and report (HCPCS:88173)
• Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 3-5 targets (HCPCS:87505)
• Cell examination of specimen, selective cellular enhancement technique (HCPCS:88112)
• Detection test by nucleic acid for human papillomavirus (hpv), high-risk types (HCPCS:87624)
• Microscopic genetic analysis of tissue, computer-assisted technology, initial procedure, each multiplex procedure (HCPCS:88374)
• Pathology examination of tissue using a microscope, limited examination (HCPCS:88300)
• Detection test by nucleic acid for mycoplasma pneumoniae (bacteria), amplified probe technique (HCPCS:87581)
• Detection test by nucleic acid for chlamydia pneumoniae, amplified probe technique (HCPCS:87486)
• Detection test by nucleic acid for digestive tract pathogen, multiple types or subtypes, 6-11 targets (HCPCS:87506)
• Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision (HCPCS:G0123)
• Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method (HCPCS:G0416)
• Special stained specimen slides to examine tissue, each multiplex procedure (HCPCS:88344)
• Detection test for candida species (yeast), amplified probe technique (HCPCS:87481)
• Detection test for candida species (yeast), direct probe technique (HCPCS:87480)
• Detection test for gardnerella vaginalis (bacteria), direct probe technique (HCPCS:87510)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), direct probe technique (HCPCS:87660)
• Detection test by nucleic acid for human papillomavirus (hpv), types 16 and 18 only (HCPCS:87625)
• Examination of archival tissue for genetic analysis (HCPCS:88363)
• Pathology examination of specimen during surgery, first tissue block (HCPCS:88331)
• Detection test by nucleic acid for herpes simplex virus, amplified probe technique (HCPCS:87529)
• Pap test (HCPCS:88141)
• Detection test by nucleic acid for clostridium difficile, amplified probe technique (HCPCS:87493)
• Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, requiring interpretation by physician (HCPCS:G0124)
• Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test (HCPCS:G0476)
• Detection test by nucleic acid for neisseria gonorrhoeae (gonorrhoeae bacteria), amplified probe technique (HCPCS:87591)
• Detection test by nucleic acid for chlamydia trachomatis, amplified probe technique (HCPCS:87491)
• Pathology examination of tissue using a microscope (HCPCS:88302)
• Pathology examination of tissue using a microscope, high complexity (HCPCS:88309)
• Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique (HCPCS:87651)
• Detection test for gardnerella vaginalis (bacteria), amplified probe technique (HCPCS:87511)
• Detection test by nucleic acid for trichomonas vaginalis (genital parasite), amplified probe technique (HCPCS:87661)

The enumeration date for this NPI number is 7/10/2006 and was last updated on 10/18/2024.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.